Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation

Blood

Volumn 88, Issue 9, 1996, Pages 3288-3298

  O'Malley, C J ^b   Rasko, J E J ^b   Basser, R L ^b   McGrath, K M ^b   Cebon, J ^b   Grigg, A P ^b   Hopkins, W ^b   Cohen, B ^b   O'Byrne, J ^b   Green, M D ^b   Fox, R M ^b   Berndt, M C ^b   Begley, C G ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ARACHIDONIC ACID; COLLAGEN; FIBRINOGEN; FIBRINOGEN RECEPTOR; GLYCOCALICIN; HEMOPOIETIC GROWTH FACTOR; MACROGOL; MONOCLONAL ANTIBODY; PADGEM PROTEIN; RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; RISTOCETIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOLID TUMOR; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE VOLUME; THROMBOCYTOPOIESIS;

EID: 10344238601     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.9.3288.bloodjournal8893288     Document Type: Article

References (44)

1. Chang M-S, McNinch J, Basu R, Shutter J, Hsu R-Y, Perkins C, Mar V, Suggs S, Welcher A, Li L, Lu H, Bartley T, Hunt P, Martin F, Samal B, Bogenberger J: Cloning and characterisation of the human megakaryocyte growth and development factor (MGDF) gene. J Biol Chem 270:511, 1995
2. Sohma Y, Akahori H, Naohiko S, Hori T-A, Ogami K, Kato T, Shimada Y, Kawamura K, Miyazaki H: Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Lett 353:57, 1994
3. Bartley, TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Chang MS, Samal B, Nichol JL, Swift S, Johnson MJ, Hsu R-Y, Parker VP, Suggs S, Skrine JD, Merewether LA, Clogston C, Hsu E, Hokom MM, Hornkohl A, Choi E, Pangelinan M, Sun Y, Mar V, McNinch J, Simonet L, Jacobsen F, Xie C, Shutter J, Chute H, Basu R, Selander L, Trollinger D, Sieu L, Padilla D, Trail G, Elliott G, Izumi R, Covey T, Crouse J, Garcia A, Xu W, Del Castillo J, Biron J, Cole S, Hu MCT, Pacifici R, Ponting I, Saris C, Wen D, Yung YP, Lin H, Bosselman RA: Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77:1117, 1994
4. Kaushansky K, Broudy VC, Lin N, Jorgensen MJ, McCarty J, Fox N, Zucker-Franklin D, Lofton-Day C: Thrombopoietin, the mpl ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA 92:3234, 1995
5. Kuter DJ, Rosenberg RD: The reciprocal relationship of thrombopoietin (c-mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 85:2720, 1995
6. Zeigler FC, de Sauvage F, Widmer HR, Keller GA, Donahue C, Schreiber RD, Malloy B, Hass P, Eaton D, Matthews W: In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine haematopoietic stem cells. Blood 84:4045, 1994
7. Nichol J, Hokom MM, Hornkohl A, Sheridan WP, Ohashi H, Kato T, Li YS, Bartley TD, Choi E, Bogenberger J, Skrine JD, Knudten A, Chen J, Trail G, Sleeman L, Cole S, Grampp G, Hunt P: Megakaryocyte growth and development factor: Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia. J Clin Invest 95:2973, 1995
8. Debili N, Wendung F, Katz A, Guichard J, Breton-Gorius J, Hunt P, Vainchenker W: The mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 86:2516, 1995
9. Choi ES, Hokom M, Bartley T, Li Y-S, Ohashi H, Kato T, Nichol JL, Skrine J, Knudten A, Chen J, Hornkohl A, Grampp G, Sleeman L, Cole S, Trail G, Hunt P: Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-mpl, produces functional human platelets in vitro. Stem Cells 13:317-322, 1995
10. Ulich TR, del Castillo J, Yin S, Swift S, Padilla D, Senaldi G, Bennett L, Shutter J, Bogenberger J, Sun D, Samal B, Shimamoto G, Lee R, Steinbrink R, Boone T, Sheridan WT, Hunt P: Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice. Blood 86:971, 1995
11. Farese AM, Hunt P, Boone T, MacVittie TJ: Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates. Blood 86:54, 1995
12. Begley CG, Metcalf D, Lopez AF, Nicola NA: Fractionated populations of normal human marrow cells respond to both human colony stimulating factors with granulocyte-macrophage activity. Exp Hematol 13:956, 1985
13. Lopez AF, Begley CG, Williamson DJ, Warren DJ, Vadas MA, Sanderson CJ: Murine eosinophil differentiation factor: An eosinophil-specific colony-stimulating factor with activity on human cells. J Exp Med 163:1085, 1986
14. Lopez AF, Williamson DJ, Gamble JR, Begley CG, Harlan JM, Klebanoff JS, Waltersdorph A, Wong G, Clark SC, Vadas MA: A recombinant human granulocyte-macrophage colony stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression and survival. J Clin Invest 78:1220, 1986
15. Metcalf D, Begley CG, Johnson GR, Nicola NA, Vadas MA, Lopez AF, Williamson DJ, Wong CG, Clark SC, Wang EA: Biological properties in vitro of a recombinant human granulocyte-macrophage colony stimulating factor. Blood 67:37, 1986
16. Begley CG, Lopez AF, Nicola NA, Warren DJ, Vadas MA, Sanderson CJ: Survival in vitro of mature human neutrophils and eosinophils in a lineage-specific manner: A rapid sensitive microassay for colony-stimulating factors. Blood 68:162, 1986
17. Metcalf D, Begley CG, Williamson DJ, Nice EC, DeLaMarter JF, Merrod JJ, Thatcher D, Schmidz A: Hemopoietic responses in mice injected with purified recombinant murine GM-CSF. Exp Hematol 15:1, 1987
18. Metcalf D, Begley CG, Johnson GR, Nicola NA, Lopez AF, Williamson DJ: Effects of purified, bacterially synthesized murine multi-CSF (IL3) on haemopoiesis in normal adult mice. Blood 68:46, 1986
19. Debili N, Wendling F, Cosman D, Titeux M, Florindo C, Dusanter-Fourt I, Schooley K, Methis N, Charon M, Nador R, Bettaieb A, Vainchenker W: The mpl receptor is expressed in the megakaryocyte lineage from late progenitors to platelets. Blood 85:391, 1995
20. Harker LA, Hunt P, Marzeo UM, Kelly AB, Tomer A, Hanson SR, Stead RB: Regulation of Platelet production and function by megakaryocyte growth and development factor in nonhuman primates. Blood 87:1833, 1996
21. Oda A, Miyakawa Y, Druker BJ, Handa M, Kato T, Miyazaki H, Shimosaka A, Ikeda Y: Thrombopoietin primed human platelet aggregation induced by shear stress, ADP, epinephrine, serotonin, vasopressin or collagen in a manner independent of thromboxane production. Blood 86:21a, 1995 (abstr, suppl 1)
22. Chen J, Herceg-Harjacek L, Groopman JE, Grabarek J: Regulation of platelet activation in vitro by the c-mpl ligand, thrombopoietin. Blood 86:285a, 1995 (abstr. suppl 1)
23. Abrams C, Shattil SJ: Immunological detection of activated platelets in clinical disorders. Thromb Haemost 65:467, 1991
24. Heynen HF, Lozano Molero M, de Groot PG, Niewenhuis HK, Sixma JJ: Absence of ligands bound to glycoprotein IIb-IIIa on the exposed surface of a thrombus may limit thrombus growth in flowing blood. J Clin Invest 94:1098, 1994
25. Richards EM, Baglin TP: Quantitation of reticulated platelets: Methodology and clinical application. Br J Haematol 91:445, 1995
26. Beer JH, Buchi L, Steiner B: Glycocalicin: A new assay - The normal plasma levels and its potential usefulness in selected diseases. Blood 83:691, 1994
27. Basser RL, Rasko JEJ, Clarke K, Cebon J, Green MD, Hussein S, Menchaca D, Tomita D, Marty J, Fox RM, Begley CG: Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF). Lancet 1996 (in press)
28. Kouns WC, Wall CD, White MM, Fox CF, Jennings LK: A conformation-dependent epitope of human platelet glycoprotein IIIa. J Biol Chem 33:20594, 1990
29. Berndt MC, Du X, Booth WJ: Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex. Biochemistry 27:633, 1988
30. Wilcox GR, Berndt MC, Mehrabani PA, Exner T, Trudinger BJ: An improved method for measuring plasma glycocalicin in the investigation of causes of thrombocytopenia. Platelets 2:45, 1991
31. Romp KG, Peters WP, Hoffman M: Reticulated platelet counts in patients undergoing autologous bone marrow transplantation: An aid in assessing marrow recovery. Am J Hematol 46:319, 1994
32. Pelzer H, Schwarz A, Stuber W: Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide. Throm Haemost 65:153, 1991
33. Basu D, Gallus A, Hirsh J, Cade J: A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med 287:324, 1972
34. Grignani G, Pacchiarini L, Ricetti MM, Dionigi P, Jemos V, Zucchella M, Fratino P: Mechanisms of platelet activation by cultured human cancer cells and cells freshly isolated from tumor tissues. Invasion Metastasis 9:298, 1989
35. Tangun Y: Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders. Thromb Diath Haemorrh 25:241, 1971
36. Honda S, Tomiyama Y, Pelletier AJ, Annis D, Honda Y, Orcheowski R, Ruggeri Z, Kunicki TJ: Topography of ligand-induced binding sites, including a novel cation-sensitive epitope (Albert Park 5) at the amino terminus, of the human integrin beta 3 subunit. J Biol Chem 270:11947, 1995
37. Dale GL, Friese P, Hynes LA, Burstyn SA: Demonstration that thiazole-orange-positive platelets in the dog are less than 24 hours old. Blood 85:1822, 1995
38. Kienast J, Schmitz G: Flow cytometric analysis of thiazole orange uptake by platelets: A diagnostic aid in the evaluation of thrombocylopenic disorders. Blood 75:116, 1990
39. Kunishima S, Hattori M, Kobayashi S, Hattori H, Iwama Y, Imai Y, Ogawa K, Naoe T, Ohno R: Activation and destruction of platelets in patients with rheumatic heart disease. Eur Heart J 15:335, 1994
40. Orchard MA, Goodchild CS, Prentice CR, Davies JA, Benoit SE, Creighton-Kemsford LJ, Gaffney PJ, Michelson AD: Aprotinin reduces cardiopulmonary bypass-induced blood loss and inhibits fibrinolysis without influencing platelets. Br J Haematol 85:533, 1993
41. Michelson AD, Benoit SE, Kroll MH, Li JM, Rohrer MJ, Kestin AS, Barnard MR: The activation-induced decrease in the platelet surface expression of the glycoprotein Ib-IX complex is reversible. Blood 83:3562, 1994
42. Harker LA: Kinetics of thrombopoiesis. J Clin Invest 47:458, 1968
43. Levin J, Bessman JD: The inverse relation between platelet volume and platelet number. J Lab Clin Med 101:295, 1983
44. Bessman JD: The relation of megakaryocyte ploidy to platelet volume. Am J Hematol 16:161, 1984